
What Does ‘Society’ Value in New Medicines, and How Can We Know?
-
Chair(s):
Prof. Ken Paterson
Honorary Senior Research Fellow,University of Glasgow, Glasgow, United Kingdom -
Session description:
Interactive Workshop
Ms. Ailsa Brown
Principal Health Economist, Scottish Medicines Consortium, Glasgow, United KingdomInteractive workshop
Professor Rachel Baker
Professor of Health Economics, Glasgow Caledonian University, Glasgow, United KingdomInteractive workshop
Dr Tom Caparrotta
Lecturer in Clinical Pharmacology, University of Edinburgh, Edinburgh, United KingdomInteractive workshop
Dr Anna Zecharia
Director of Policy and Public Affairs, British Pharmacological Society, London, United Kingdom
Speakers
-
Ailsa BrownPrincipal Health Economist,Scottish Medicines Consortium, Glasgow, United Kingdom
-
Dr Anna ZechariaDirector of Policy and Public Affairs,British Pharmacological Society, London, United Kingdom
-
Dr Tom CaparrottaLecturer in Clinical Pharmacology,University of Edinburgh, Edinburgh, United Kingdom
-
Professor Rachel BakerProfessor of Health Economics,Glasgow Caledonian University, Glasgow, United Kingdom
Leave A Comment